Advertisement

Langenbeck's Archives of Surgery

, Volume 394, Issue 5, pp 837–842 | Cite as

The effectiveness of FloSeal® matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study

  • Mario TestiniEmail author
  • Rinaldo Marzaioli
  • Germana Lissidini
  • Agostino Lippolis
  • Francesco Logoluso
  • Angela Gurrado
  • Domenica Lardo
  • Elisabetta Poli
  • Giuseppe Piccinni
Original Article

Abstract

Background

The objective of this study was to compare the effectiveness of FloSeal® matrix hemostatic agent with hemostatic surgical procedures and Tabotamp® in thyroid surgery.

Methods

One hundred fifty-five consecutive total thyroidectomy patients were recruited at our institution between January 2005 and December 2007. Exclusion criteria were applied. Patients were randomized to one of three hemostatic approaches: 49 received surgical procedures only, and 52 received oxidized regenerated cellulose patch (Tabotamp Fibrillar 2.5 × 5 cm) and 54 FloSeal (5,000 U/5 mL). The same surgeon performed all operations.

Results

Mean operating time was reduced in the FloSeal group (105 min) vs. surgical (133 min, p = 0.02) and vs. Tabotamp (122 min, p = 0.0003). Also, wound drain removal occurred earlier with FloSeal (p = 0.006 vs. surgical; p = 0.008 vs. Tabotamp) resulting in shorter postoperative hospital stay in the FloSeal group (p = 0.02 vs. surgical; p = 0.002 vs. Tabotamp).

Conclusions

FloSeal matrix is an effective additional agent to conventional haemostatic procedures in thyroid surgery.

Keywords

Thyroidectomy Hemorrhagic complication FloSeal Tabotamp Hemostatic agent 

References

  1. 1.
    Thompson NW, Olsen WR, Hoffman GL (1973) The continuing development of the technique of thyroidectomy. Surgery 73:913–927PubMedGoogle Scholar
  2. 2.
    Rosato L, Avenia N, Bernante P et al (2004) Complications of thyroid surgery: analysis of a multicentric study on 14, 934 patients operated on in Italy over 5 years. World J Surg 28:271–276. doi: 10.1007/s00268-003-6903-1 PubMedCrossRefGoogle Scholar
  3. 3.
    Zambudio AR, Rodríguez J, Riquelme J et al (2004) Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg 240:18–25. doi: 10.1097/01.sla.0000129357.58265.3c PubMedCrossRefGoogle Scholar
  4. 4.
    Shandilya M, Kieran S, Walshe P, Timon C (2006) Cervical haematoma after thyroid surgery: management and prevention. Ir Med J 99:266–268PubMedGoogle Scholar
  5. 5.
    Reeve T, Thompson NW (2000) Complications of thyroid surgery: how to avoid them, how to manage them, and observations on their possible effect on the whole patient. World J Surg 24:971–975. doi: 10.1007/s002680010160 PubMedCrossRefGoogle Scholar
  6. 6.
    Lacoste L, Gineste D, Karayan J et al (1993) Airway complications in thyroid surgery. Ann Otol Rhinol Laryngol 102:441–446PubMedGoogle Scholar
  7. 7.
    Shaha AR, Jaffe BM (1994) Practical management of post-thyroidectomy hematoma. J Surg Oncol 57:235–238. doi: 10.1002/jso.2930570406 PubMedCrossRefGoogle Scholar
  8. 8.
    Burkey SH, van Heerden JA, Thompson GB et al (2001) Reexploration for symptomatic hematomas after cervical exploration. Surgery 130:914–920. doi: 10.1067/msy.2001.118384 PubMedCrossRefGoogle Scholar
  9. 9.
    Oz MC, Cosgrove DM 3rd, Badduke BR et al (2000) Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg 69:1376–1382. doi: 10.1016/S0003-4975(00)01194-2 PubMedCrossRefGoogle Scholar
  10. 10.
    Weaver FA, Hood DB, Zatina M et al (2002) Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg 16:286–293. doi: 10.1007/s10016-001-0073-0 PubMedCrossRefGoogle Scholar
  11. 11.
    Reuthebuch O, Lachat ML, Vogt P et al (2000) FloSeal: a new hemostyptic agent in peripheral vascular surgery. Vasa 29:204–206. doi: 10.1024/0301-1526.29.3.204 PubMedCrossRefGoogle Scholar
  12. 12.
    Pursifull NF, Morris MS, Harris RA, Morey AF (2006) Damage control management of experimental grade 5 renal injuries: further evaluation of FloSeal gelatin matrix. J Trauma 60:346–350. doi: 10.1097/01.ta.0000202514.96964.85 PubMedCrossRefGoogle Scholar
  13. 13.
    Richter F, Tüllmann ME, Türk I et al (2003) Improvement of hemostasis in laparoscopic and open partial nephrectomy with gelatin thrombin matrix (FloSeal). Urologe A 42:338–346PubMedGoogle Scholar
  14. 14.
    Gill IS, Ramani AP, Spaliviero M et al (2005) Improved hemostasis during laparoscopic partial nephrectomy using gelatin matrix thrombin sealant. Urology 65:463–466. doi: 10.1016/j.urology.2004.10.030 PubMedCrossRefGoogle Scholar
  15. 15.
    User HM, Nadler RB (2003) Applications of FloSeal in nephron-sparing surgery. Urology 62:342–343. doi: 10.1016/S0090-4295(03)00336-4 PubMedCrossRefGoogle Scholar
  16. 16.
    Durrani OM, Fernando AI, Reuser TQ (2007) Use of a novel topical hemostatic sealant in lacrimal surgery: a prospective, comparative study. Ophthal Plast Reconstr Surg 23:25–27. doi: 10.1097/IOP.0b013e31802c610b PubMedCrossRefGoogle Scholar
  17. 17.
    Ellegala DB, Maartens NF, Laws ER Jr (2002) Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note. Neurosurgery 51:513–515. doi: 10.1097/00006123-200208000-00041 PubMedCrossRefGoogle Scholar
  18. 18.
    Klemcke HG (2006) Evaluation of FloSeal as a potential intracavitary hemostatic agent. J Trauma 60:385–389. doi: 10.1097/01.ta.0000204440.48338.79 PubMedCrossRefGoogle Scholar
  19. 19.
    Mathiasen RA, Cruz RM (2005) Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis. Laryngoscope 115:899–902. doi: 10.1097/01.MLG.0000160528.50017.3C PubMedCrossRefGoogle Scholar
  20. 20.
    Baumann A, Caversaccio M (2003) Hemostasis in endoscopic sinus surgery using a specific gelatinthrombin based agent (FloSeal). Rhinology 41:244–249PubMedGoogle Scholar
  21. 21.
    Chandra RK, Conley DB, Kern RC (2003) The effect of FloSeal on mucosal healing after endoscopic sinus surgery: a comparison with thrombin-soaked gelatin foam. Am J Rhinol 17:51–55PubMedGoogle Scholar
  22. 22.
    Jameson M, Gross CW, Kountakis SE (2006) FloSeal use in endoscopic sinus surgery: effect on postoperative bleeding and synechiae formation. Am J Otolaryngol 27:86–90. doi: 10.1016/j.amjoto.2005.07.011 PubMedCrossRefGoogle Scholar
  23. 23.
    Jo SH, Mathiasen RA, Gurushanthaiah D (2007) Prospective, randomized, controlled trial of a hemostatic sealant in children undergoing adenotonsillectomy. Otolaryngol Head Neck Surg 137:454–458. doi: 10.1016/j.otohns.2006.09.020 PubMedCrossRefGoogle Scholar
  24. 24.
    Gall RM, Witterick IJ, Shargill NS, Hawke M (2002) Control of bleeding in endoscopic sinus surgery: use of a novel gelatin-based hemostatic agent. J Otolaryngol 31:271–274. doi: 10.2310/7070.2002.29810 PubMedCrossRefGoogle Scholar
  25. 25.
    Tonante A, Lo Schiavo MG, Bonanno L et al (2006) Hemorrhagic complications in thyroid surgery. Control of bleeding from retroneural vessels using collagen and thrombin gelatine granules. Chir Ital 58:61–68Google Scholar
  26. 26.
    Testini M, Nacchiero M, Piccinni G et al (2004) Total thyroidectomy is improved by loupe magnification. Microsurgery 24:39–42. doi: 10.1002/micr.10195 PubMedCrossRefGoogle Scholar
  27. 27.
    Testini M, Rosato L, Avenia N et al (2007) The impact of single parathyroid gland autotransplantation during thyroid surgery on postoperative hypoparathyroidism: a multicenter study. Transplant Proc 39:225–230. doi: 10.1016/j.transproceed.2006.10.192 PubMedCrossRefGoogle Scholar
  28. 28.
    Armitage P, Berry G (1994) Statistical methods in medical research, 3rd edn. Blackwell, OxfordGoogle Scholar
  29. 29.
    Dawson B, Trapp RG (2001) Basic & Clinical Biostatistics, 3rd edn. McGraw-Hill, New YorkGoogle Scholar
  30. 30.
    Agarwal A, Mishra SK (1997) Post-thyroidectomy hemorrhage: an analysis of critical factors in successful management. J Indian Med Assoc 95:418–419PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Mario Testini
    • 1
    Email author
  • Rinaldo Marzaioli
    • 1
  • Germana Lissidini
    • 1
  • Agostino Lippolis
    • 1
  • Francesco Logoluso
    • 2
  • Angela Gurrado
    • 1
  • Domenica Lardo
    • 1
  • Elisabetta Poli
    • 1
  • Giuseppe Piccinni
    • 1
  1. 1.Section of General and Thoracic Surgery, Department of Applications in Surgery of Innovative TechnologiesUniversity Medical School of BariBariItaly
  2. 2.Section of Endocrinology, Department of Emergency and Organ TransplantationUniversity Medical School of BariBariItaly

Personalised recommendations